Inovio Pharmaceuticals
INO
#9813
Rank
โ‚ฌ71.15 M
Marketcap
0,86ย โ‚ฌ
Share price
-3.49%
Change (1 day)
-34.82%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2026 (TTM): -1,97ย โ‚ฌ

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,99ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,59ย โ‚ฌ an increase over its 2024 EPS that were of -3,47ย โ‚ฌ.

EPS history for Inovio Pharmaceuticals from 1999 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,97ย โ‚ฌ24.01%
2025-1,59ย โ‚ฌ-54.18%
2024-3,47ย โ‚ฌ-35.14%
2023-5,35ย โ‚ฌ-56.62%
2022-12,34ย โ‚ฌ-19.54%
2021-15,33ย โ‚ฌ35.9%
2020-11,28ย โ‚ฌ-11.57%
2019-12,76ย โ‚ฌ15.24%
2018-11,07ย โ‚ฌ-2.78%
2017-11,39ย โ‚ฌ6.93%
2016-10,65ย โ‚ฌ134.88%
2015-4,53ย โ‚ฌ-29.51%
2014-6,43ย โ‚ฌ-57.34%
2013-15,08ย โ‚ฌ146.55%
2012-6,12ย โ‚ฌ20.83%
2011-5,06ย โ‚ฌ-29.41%
2010-7,17ย โ‚ฌ-48.48%
2009-13,92ย โ‚ฌ10%
2008-12,65ย โ‚ฌ11.11%
2007-11,39ย โ‚ฌ-41.3%
2006-19,40ย โ‚ฌ-66.91%
2005-58,62ย โ‚ฌ110.61%
2004-27,83ย โ‚ฌ-61.63%
2003-72,54ย โ‚ฌ186.67%
2002-25,30ย โ‚ฌ
2001N/A-100%
2000-20,24ย โ‚ฌ-62.09%
1999-53,39ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,67ย โ‚ฌ-484.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6,17ย โ‚ฌ-409.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1,15ย โ‚ฌ-157.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
6,52ย โ‚ฌ-426.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
3,14ย โ‚ฌ-257.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
3,41ย โ‚ฌ-271.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
0,71ย โ‚ฌ-135.68%๐Ÿ‡บ๐Ÿ‡ธ USA